Banque Cantonale Vaudoise Inovio Pharmaceuticals, Inc. Transaction History

Banque Cantonale Vaudoise

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$0.38 - $0.58 $790 - $1,206	-2,081 Reduced 99.9%	2 $0
Q3 2022 Oct 17, 2022	SELL	$1.66 - $2.79 $71 - $119	-43 Reduced 2.02%	2,083 $4,000
Q2 2022 Aug 02, 2022	BUY	$1.44 - $3.98 $56 - $155	39 Added 1.87%	2,126 $4,000
Q1 2022 May 09, 2022	SELL	$2.97 - $5.2 $10,991 - $19,245	-3,701 Reduced 63.94%	2,087 $7,000
Q4 2021 Feb 14, 2022	SELL	$4.99 - $7.46 $46,721 - $69,847	-9,363 Reduced 61.8%	5,788 $29,000
Q3 2021 Oct 29, 2021	SELL	$7.16 - $9.69 $2,914 - $3,943	-407 Reduced 2.62%	15,151 $108,000
Q2 2021 Aug 11, 2021	BUY	$6.23 - $10.03 $168 - $270	27 Added 0.17%	15,558 $144,000
Q1 2021 May 11, 2021	SELL	$8.81 - $16.96 $1,682 - $3,239	-191 Reduced 1.21%	15,531 $144,000
Q4 2020 Feb 05, 2021	BUY	$8.5 - $12.85 $8,117 - $12,271	955 Added 6.47%	15,722 $139,000
Q3 2020 Oct 30, 2020	BUY	$9.57 - $27.05 $66,329 - $187,483	6,931 Added 88.45%	14,767 $171,000
Q2 2020 Jul 22, 2020	BUY	$7.14 - $31.69 $55,941 - $248,291	7,835 Added 783500.0%	7,836 $211,000
Q4 2019 Feb 10, 2020	BUY	$1.97 - $3.72 $1 - $3	1 New	1 $0

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $456M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.